What is adalimumab’s AacF price?
“AACF” can refer to different pricing/contracting frameworks depending on the country, payer (government vs. private), and whether the question is about the list price, a discounted net price, or a tender/contract price. With only the phrase “adalimumab aacf price,” there isn’t enough information to give a single correct number.
If you tell me:
- your country/market (e.g., UK, France, US, India),
- whether you mean list price or net price,
- the brand (Humira or biosimilar) and dose/form (e.g., 40 mg pen/syringe, 80 mg),
I can return the exact AACF price for that specific product.
Which adalimumab product does AACF pricing usually apply to?
Adalimumab is sold as:
- the originator brand Humira, and
- multiple biosimilars (each with its own pricing and contracting/tender outcomes).
AACF-style prices (where applicable) often vary by product and pack size, so the price can differ between Humira and biosimilars even at the same dose strength.
Why adalimumab AacF price might change
Prices for adalimumab can vary because of:
- tender/contract renewals,
- negotiated payer rebates/discounts,
- biosimilar switching policies,
- pharmacy dispensing fees or VAT rules.
That’s why the same drug can show different prices across regions and payers.
What I need from you to give the exact AACF figure
Reply with the missing details:
1) Country (and if relevant, state/province)
2) AACF definition you’re using (or where you saw the term)
3) Brand/biosimilar name
4) Dose and presentation (e.g., 40 mg/0.4 mL pen)
5) Whether you want list price or the net/contract price
Once you provide that, I’ll give the adalimumab AACF price for the exact product.